M16-135
ClinicalTrials.gov NCT03089944
Research payments
$483,103
Through program year 2020, $483,103 in research payments was reported against M16-135, across 212 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03089944
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $191,444 | 64 |
| 2019 | Research | $291,659 | 148 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Franco Felizarta Bakersfield, CA Named on 49 payments
- Barbara Rosado Ponce, PR Named on 19 payments
- Richard Sterling Richmond, VA Named on 17 payments
- Gladys Sepulveda Ponce, PR Named on 10 payments
- Alonzo Williams Little Rock, AR Named on 9 payments
- Brian Borg Jackson, MS Named on 9 payments
- Linda Law New York, NY Named on 7 payments
- Michael Lucey Madison, WI Named on 7 payments
- Susanna Naggie Durham, NC Named on 6 payments
- Timothy Morgan Long Beach, CA Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.